Phosphoramidite Market Research 2026: Market Size, Trends, Segments And Growth Forecast
Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
#Phosphoramidite Market Set To Climb From $1.14 Billion In 2026 To $1.49 Billion By 2030#_x000D_
The phosphoramidite market has demonstrated strong growth in recent years. Its value is projected to increase from $1.07 billion in 2025 to $1.15 billion in 2026, progressing at a compound annual growth rate (CAGR) of 7.1%. The expansion observed in the past can be attributed to several factors including a surge in DNA sequencing activities, increased funding for academic research, wider application of synthetic nucleic acids, advancements in solid-phase synthesis techniques, and a rising requirement for molecular diagnostics._x000D_
_x000D_
The phosphoramidite market is poised for substantial growth over the next few years. This market is expected to reach $1.5 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.9%. This growth throughout the forecast period stems from factors such as the expansion of RNA-based therapeutics, advancements in gene editing technologies, increased investment in pharmaceutical research and development, a rising demand for custom oligonucleotides, and the scaling up of automated synthesis platforms. Furthermore, significant trends anticipated during the forecast period involve a growing demand for oligonucleotide synthesis materials, the expansion of gene therapy and RNA therapeutics, their increasing utilization in diagnostic and research applications, the rising adoption of automated solid-phase synthesis, and a heightened focus on high-purity chemical inputs._x000D_
_x000D_
#Get A Free Sample Report With In-Depth Market Insights:#_x000D_
_x000D_
#Phosphoramidite Market Growth Drivers: What’s Behind The Acceleration?#_x000D_
The anticipated expansion of the biopharmaceutical sector is set to fuel the growth of the phosphoramidite market in the future. This sector encompasses the industry involved in the research, development, production, and commercialization of medical products derived from biological sources, including vaccines, gene therapies, monoclonal antibodies, and recombinant proteins. The growth of the biopharmaceutical sector is attributed to advancements in biotechnology, the increasing prevalence of chronic diseases, and rising investments in research and development. Biotechnology innovations, such as gene editing and monoclonal antibody therapies, have enabled the creation of more effective and targeted treatments. For example, in October 2025, the Office for National Statistics, a UK-based government department, reported that in 2024, the UK life sciences industry consisted of 6,170 businesses operating across 7,320 sites, employing 359,600 people and generating $191 billion (£146.9 billion) in turnover. The medical technology subsector was the largest by both company count and workforce, accounting for 60% of all companies and 55% of total employment. Consequently, the expanding biopharmaceutical sector is a significant driver for the growth of the phosphoramidite market._x000D_
_x000D_
#Phosphoramidite Market Segments: Where Is Growth Concentrated?#_x000D_
The phosphoramidite market covered in this report is segmented – _x000D_
_x000D_
1) By Type: Deoxyribonucleic Acid (DNA) Phosphoramidites, Ribonucleic Acid (RNA) Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites, Other Types_x000D_
2) By Synthesis Method: H-Phosphonate Method, Phosphoramidite Method, Trivalent Phosphorus Compounds Method_x000D_
3) By Application: Gene Synthesis, Deoxyribonucleic Acid (DNA) Sequencing, Deoxyribonucleic Acid (DNA) Amplification_x000D_
4) By End-User: Academic Research, Pharmaceutical Industry, Biotechnology Industry_x000D_
_x000D_
Subsegments:_x000D_
1) By Deoxyribonucleic Acid (DNA) Phosphoramidites: Standard DNA Phosphoramidites, Degenerate DNA Phosphoramidites, Methylated DNA Phosphoramidites, Backbone-Modified DNA Phosphoramidites_x000D_
2) By Ribonucleic Acid (RNA) Phosphoramidites: Standard RNA Phosphoramidites, 2′-O-Methyl RNA Phosphoramidites, 2′-Fluoro RNA Phosphoramidites, 2′-O-TBDMS Protected RNA Phosphoramidites_x000D_
3) By Labeled Phosphoramidites: Fluorescent-Labeled Phosphoramidites, Biotin-Labeled Phosphoramidites, Digoxigenin-Labeled Phosphoramidites, Radioisotope-Labeled Phosphoramidites_x000D_
4) By Modifier Phosphoramidites: Amine-Modified Phosphoramidites, Thiol-Modified Phosphoramidites, Spacer Phosphoramidites, Azide-Modified Phosphoramidites_x000D_
5) By Other Types: Chimeric Phosphoramidites, Phosphorothioate Phosphoramidites, PEGylated Phosphoramidites, Photo-Cleavable Phosphoramidites_x000D_
_x000D_
#Phosphoramidite Market Trends: What’s Defining The Industry’s Next Phase?#_x000D_
Key companies within the phosphoramidite market are concentrating on developing advanced DNA synthesis methods, such as utilizing convertible-preferred stock financing rounds, to boost the adoption and progress of Gibson SOLA technology for rapid DNA and mRNA synthesis. Convertible-preferred stock financing is defined as a capital-raising approach where a company issues preferred shares that can subsequently be converted into a predetermined count of common shares. For example, in March 2025, Telesis Bio Inc., a US-based biotechnology company, announced it had secured up to $21 million in new financing from several strategic investors to accelerate the commercialization of its next-generation enzymatic DNA synthesis platform, Gibson SOLA. This funding aims to scale the company’s fully enzymatic DNA synthesis technology, expand its research and development along with manufacturing capabilities, and broaden access to rapid, customizable long-DNA production. The company employs a proprietary enzymatic method that enables quick and precise synthesis of long DNA sequences, thereby addressing current limitations linked with traditional phosphoramidite-based approaches._x000D_
_x000D_
#Phosphoramidite Market Key Participants And Competitive Landscape#_x000D_
Major companies operating in the phosphoramidite market are Thermo Fisher Scientific Inc., Agilent Technologies Inc., Aragen Life Sciences, Twist Bioscience, Innovassynth Technologies (I) Ltd., Tokyo Chemical Industry Co. Ltd. (TCI), Aurigene Services, Eurofins Genomics, LGC Biosearch Technologies, Link Technologies Ltd., Creative Biolabs, Biosynth Carbosynth, TriLink BioTechnologies, ChemGenes Corporation, Berry & Associates Inc., Lumiprobe Corporation, Hongene Biotech Corporation, Carbolink India Pvt. Ltd., PolyOrg Inc., Glen Research, Gene Link Inc., emp BIOTECH GmbH _x000D_
_x000D_
#View The Full Phosphoramidite Market Report:#_x000D_
_x000D_
#Phosphoramidite Market Regional Analysis And Leading Geography#_x000D_
North America was the largest region in the phosphoramidite market in 2025. Europe is expected to be the fastest-growing region during the forecast period. The regions covered in the phosphoramidite market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Reach Out To Our Team:#_x000D_
_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas: +1 310-496-7795_x000D_
Asia: +44 7882 955267 & +91 8897263534_x000D_
Europe: +44 7882 955267_x000D_
Email us at: marketing@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
